FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Naratriptan Hydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

GlaxoSmithKline (New 04/07/2022)

Company Contact Information:
888-825-5249

Presentation Posting Date Related Information
1 mg 9-count blisterpack (NDC 0173-0561-00) 04/07/2022 This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately May, 2022.
2.5 mg 9-count blisterpack (NDC 0173-0562-00) 04/07/2022 This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately August, 2022.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English